Arrhythmias & electrophysiology

Catheter Ablation Outcomes and Life Expectancy in Very Elderly Atrial Fibrillation Patients: The REHEALTH Atrial Fibrillation (AF) Study

JACC Clin ElectrophysiolPublished Prospective registry-based observational study

Main finding · Composite of stroke, TIA, systemic embolism, CV events, bleeding or all-cause deathResult — go to the resultAdjusted hazard ratio 0.44

Authors' conclusion

Although ablation improved functional and structural outcomes, its prognostic benefit was limited without adjustment but emerged after multivariable correction.

Study context

Population
Patients aged ≥80 years with nonvalvular AF, 47 hospitals in Japan, June 2022–December 2023
Participants
703 patients
Exposure
Catheter ablation vs nonablation management
  • Ablationn = 249
  • Nonablationn = 454reference
Outcome
Composite of:
  • Stroke
  • TIA
  • Systemic embolism
  • CV events
  • Bleeding
  • All-cause death
Follow-up
Median 504 days (Q1-Q3: 375-667 days)
Methodological detailsmulticentre, 47 hospitals in Japan
  • Multicentre
  • 47 hospitals in Japan

Main finding

As reported in the abstract

Adjusted hazard ratio

0.44

P = 0.029

Observational data: associations, not effects.

Further findings

Symptoms, quality of life, NT-proBNP, left atrial diameter, Mini-Mental State Examination and frailty scores · 1 year

Ablation improved symptoms, quality of life, NT-proBNP and left atrial diameter, with better preservation of MMSE and frailty scores; significant after adjustment

Original publication

Catheter Ablation Outcomes and Life Expectancy in Very Elderly Atrial Fibrillation Patients: The REHEALTH AF Study. JACC Clin Electrophysiol. Published 24 November 2025. doi:10.1016/j.jacep.2025.10.007

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.